ACM
ALNA

AIGH Capital Management’s Allena Pharmaceuticals ALNA Stock Holding History

AIGH Capital Management’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,000,000
Closed -$2.37M – 56
2021
Q4 		$2.37M Hold
4,000,000
– – 0.72% 33
2021
Q3 		$3.61M Hold
4,000,000
– – 0.76% 30
2021
Q2 		$5.2M Hold
4,000,000
– – 0.94% 25
2021
Q1 		$5.56M Buy
4,000,000
+2,000,000
+100% +$3.33M 1.17% 25
2020
Q4 		$2.56M Buy
+2,000,000
New +$2.79M 1.04% 26

Other funds holding ALNA

TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

AIGH Capital Management's ALNA Position: Q1 2022 in Review

AIGH Capital Management sold out of Allena Pharmaceuticals (ALNA) in Q1 2022, closing a stake of 4,000,000 shares — an estimated $2.37M sold.

AIGH Capital Management first reported a position in ALNA in Q4 2020 and held it in 5 quarters. The position peaked at $5.56M in Q1 2021. 28 funds tracked by Wall St. Rank hold ALNA as of Q1 2022.

  • AIGH Capital Management reported no remaining Allena Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • AIGH Capital Management sold 4,000,000 Allena Pharmaceuticals shares in Q1 2022, an estimated $2.37M.
  • AIGH Capital Management first reported a position in Allena Pharmaceuticals in Q4 2020 and held it in 5 quarters.
  • AIGH Capital Management's Allena Pharmaceuticals position peaked at $5.56M in Q1 2021.
  • 28 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q1 2022.

Based on AIGH Capital Management's 13F filing for Q1 2022, filed 12 May 2022.